KINNATE BIOPHARMA INC shareholders Q3 2023

KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 60 filers reported holding KINNATE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.

KINNATE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 3,525,957$4,936,3407.88%
Foresite Capital Management IV, LLC 9,671,643$13,540,3007.52%
Vida Ventures Advisors, LLC 2,207,772$3,090,8814.78%
Lynx1 Capital Management LP 1,997,006$2,795,8081.85%
Nextech Invest Ltd. 2,329,480$3,261,2720.99%
Orbimed Advisors 8,009,729$11,213,6210.24%
Novo Holdings A/S 815,707$1,141,9900.08%
DAFNA Capital Management LLC 105,179$147,2510.05%
GSA CAPITAL PARTNERS LLP 374,291$5240.04%
Rock Springs Capital Management LP 405,811$568,1350.02%
XTX Topco Ltd 48,863$68,4080.01%
Pale Fire Capital SE 70,174$98,2440.01%
VIKING GLOBAL INVESTORS LP 1,820,462$2,548,6470.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 144,300$202,0200.01%
ACADIAN ASSET MANAGEMENT LLC 736,686$1,0300.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 449,453$629,2340.00%
Sargent Investment Group, LLC 12,398$17,3570.00%
PRELUDE CAPITAL MANAGEMENT, LLC 32,309$45,2330.00%
TWO SIGMA INVESTMENTS, LP 137,470$192,4580.00%
Verition Fund Management LLC 70,000$98,0000.00%
External links

This page lists KINNATE BIOPHARMA INC's shareholders in Q3 2023. To view KINNATE BIOPHARMA INC's shareholder history, click here.